UCERIS (budesonide ER)

SELF ADMINISTRATION – ORAL

Indications for Prior Authorization:

  • Approvable for induction of remission in patients with active, mild to moderate ulcerative colitis

Patients must meet the following criteria for the indication(s) above:

  • Diagnosis of ulcerative colitis

The Following Conditions Do Not Meet the Criteria for Use as Established by the WHA P&T Committee:

  • All non-FDA approved uses not listed in the approved indications

Recommended Dosing:

  • 9 mg once daily

Duration:

  • Maximum duration of therapy is 8 weeks

Approval: 

Eight weeks


 

Last review date: December 3, 2013

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone